AC Immune (ACIU) Change in Account Payables (2015 - 2025)
AC Immune (ACIU) posted quarterly Change in Account Payables of $414137.2 for Q4 2025, down 70.79% year-over-year from $1.4 million in Q4 2024, and up 128.44% quarter-over-quarter from -$1.5 million in Q3 2025.
Analysis
AC Immune (ACIU) Change in Account Payables (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Change in Account Payables for 11 consecutive years, with $414137.2 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Account Payables fell 70.79% year-over-year to $414137.2; the TTM figure through Dec 2025 stood at -$713779.1 (down 161.01% YoY), while the FY2025 annual figure was -$714028.1, down 164.02% from the prior year.
- Change in Account Payables rose to $414137.2 in Q4 2025 per ACIU's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.0 million in Q4 2021 and bottomed at -$2.0 million in Q1 2021.
- Historically, Change in Account Payables has averaged -$123.93 across 5 years, with a median of $64889.3 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 1678.46% — and 2025, when it sank 6541.05%.
- AC Immune's Change in Account Payables stood at $2.0 million in 2021, then sank by 137.01% to -$727653.4 in 2022, then jumped by 131.45% to $228853.0 in 2023, then surged by 519.51% to $1.4 million in 2024, then plunged by 70.79% to $414137.2 in 2025.
- Business Quant data shows ACIU's Change in Account Payables at $414137.2 in Q4 2025, -$1.5 million in Q3 2025, and $748891.9 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 414,137.20 |
| Sep 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | 748,891.94 |
| Mar 31, 2025 | -420,430.70 |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -21,929.94 |
| Jun 30, 2024 | -1.55 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 228,852.96 |
| Sep 30, 2023 | 151,708.44 |
| Jun 30, 2023 | 250,239.50 |
| Mar 31, 2023 | 224,881.82 |
| Dec 31, 2022 | -727,653.36 |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | -94,484.66 |
| Mar 31, 2022 | -1.62 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | -79,506.43 |
| Jun 30, 2021 | -28,512.82 |
| Mar 31, 2021 | -1.99 Mn |